Not a good buy right now: the dominant trend is still bearish (SMA_200 > SMA_20 > SMA_5) while the company’s latest quarter shows a severe revenue collapse.
With no Intellectia signals (no AI Stock Picker, no SwingMax) and no news catalysts, there’s no strong edge for an impatient entry.
Pre-market price (~0.3546) is sitting right on the pivot (0.355): upside exists toward 0.389/0.41, but the broader setup + fundamentals make this more of a speculative bounce than a high-conviction buy.
Momentum: MACD histogram is positive (0.0043) and expanding, suggesting short-term momentum is improving (potential bounce), but not enough to override bearish structure.
RSI (6): 50.603 (neutral), indicating no oversold rebound signal and no strong bullish confirmation.
Key levels: Price ~0.3546 is essentially at Pivot 0.355.
Upside resistances: R1 0.389, R2 0.41.
Downside supports: S1 0.321, S2 0.299.
Pattern-based projection provided: 70% chance of very small move next day (0.42%), flat-ish week (0.04%), and modest month (5.32%)—not compelling for an immediate buy.
Positive Catalysts
No notable hedge fund or insider selling pressure flagged recently (both “Neutral”).
Neutral/Negative Catalysts
increases the odds that rallies fail.
with tight supports below (0.321/0.299): breakdown risk is meaningful.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 106,592, down -96.00% YoY (major deterioration in top-line demand/scale).
Net income: -2,780,648 (still deeply negative), though improved 93.12% YoY (loss narrowed vs prior year).
EPS: -0.48, down -77.14% YoY (worse per-share performance year over year).
Gross margin: -92.05 (negative) and down -321.27% YoY, indicating severe profitability/operating efficiency issues.
Overall: the quarter shows extreme revenue contraction and structurally weak profitability—fundamentals do not support a confident “buy now.”
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided, so there’s no evidence of improving Wall Street conviction.
Wall Street pro view (based on available data only):
Pros: none clearly signaled via upgrades/targets in the provided dataset.
Cons: fundamentals (revenue collapse, negative gross margin) and bearish long-term technical structure would typically keep professional sentiment cautious.
Wall Street analysts forecast ISPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ISPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
